Skip to content

Effect of Leech therapy in Diabetic Peripheral Neuropathy

Clinical Efficacy of Jalaukavacharana (Leech therapy) in Diabetic Peripheral Neuropathy- A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055358
Enrollment
80
Registered
2023-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both the genders having the age between 30 to 75 years. Presence of any classical symptoms i.e., pain, burning sensation, numbness, tingling sensation, insensitivity to Vibration and hot or cold in feet. Patients with clinical positive history of diabetes mellitus having the symptoms of diabetic peripheral neuropathy will be selected for the present study. Patients having BSL (FBS

Exclusion criteria

Exclusion criteria: Patients having any other associated clinical conditions influencing peripheral nerve function. (like Chronic Kidney Disease) Age below 30 years and above 75 years. Patients having BSL (FBS >200 mg/dl & PPBS >400 mg/dl). Pregnancy and Lactating women. Severe Anaemia (Hb Haemolytic disorders â?? ITP (Immune thrombocytopenia), Haemophillia, and Thalassemia contraindicated / unfit for Jalaukavacharana (Leech Therapy). Blood borne infections.

Design outcomes

Primary

MeasureTime frame
Sensations by Neuropathy Analyzer Vibrotherm Diagnostic testTimepoint: Baseline, Third week and Six Week

Secondary

MeasureTime frame
Appearance of feet by MNSITimepoint: Baseline, Third week & Six Week;Foot Ulceration by MNSITimepoint: Baseline, Third week & Six Week;Ankle reflexes by MNSITimepoint: Baseline, Third week & Six Week;Vibration perception by MNSITimepoint: Baseline, Third week & Six Week;Monofilament test by MNSITimepoint: Baseline, Third week & Six Week

Countries

India

Contacts

Public ContactDr T S Dudhamal

Institute of Teaching and Research in Ayurveda

pritiengineer005@gmail.com8758172998

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026